TERT and meningioma: In the future, treatment decisions, might be based on histomorphological features, as well as molecular parameters, such as telomerase reverse transcriptase (TERT) promoter mutations, and methylation profiling, which have proven to be of prognostic value in meningiomas [63,64,65], and CSF and serum proteomics have a potential role in the early diagnosis and histopathological characterization.